Stock Analysts

Regal Beloit Beats on Q4 Earnings

Industrial equipment manufacturer Regal Beloit Corporation ( RBC ) reported fourth-quarter 2013 net loss of $33.2 million or 74 cents per share versus net income of $29.9 million or 70 cents per share in the year-ago quarter. The results were impacted by goodwill and asset impairments and higher share count. […]

Stock Analysts

Korea Electric Power Turns to Profit in 2013

South Korean utility major, Korea Electric Power Corporation ( KEP ) recorded a net income of KRW 636 billion (US $572.4 million) in the fourth quarter of 2013 versus a loss of KRW 1,756 billion in the year-ago period. In 2013, the country’s monopoly distributor reported net income of KRW 186 billion (US $167.4 million), compared with a net loss of KRW 3,078 billion (US$2,770.2 million) in 2012. […]

Stock Analysts

Q4 Earnings Beat at CNA Financial; Div Up

CNA Financial Corporation ’s ( CNA ) fourth-quarter 2013 earnings of $1.24 per share far exceeded the Zacks Consensus Estimate of 85 cents per share. Net premium written at CNA Financial increased 4.7% year over year to $1.7 billion, led by higher contribution from the Specialty and Hardy segments, partly offset by lower contribution from the Commercial line of business. CNA Financial's property & casualty operations' net operating income came in at $340 million, up 5.7 times year over year […]

Stock Analysts

Icahn Backtracks on Apple Share Buyback

Apple ( AAPL ) management can breathe a sigh of relief after activist investor Carl Icahn dropped his aggressive share buyback proposal for the time being. The proposal that drew a flurry of attention over the last six months received a jolt over the weekend, when Institutional Shareholder Services Inc. (ISS) backed Apple’s strategy of holding cash […]

Mergers & Acquisitions

Blaze Energy to Acquire Kentucky Energy Company

Blaze Energy to Acquire Kentucky Energy Company PR Newswire BOISE, Idaho, Feb. 11, 2014 BOISE, Idaho , Feb. 11, 2014 /PRNewswire/ — Blaze Energy (OTC Markets: BLZE) today announced it has executed a definitive agreement to acquire Kentucky Diversified Fuels, LLC (“KDF”), a recently consolidated energy company with operations in eastern Kentucky , consisting of a steam coal strip-mining company, Middle Fork Development Services, LLC (“MFDS”), a development stage coal-to-liquid company, MXP, LLC (“MXP”), and a coal feedstock impoundment, situated on 24.68 acres, with approximately 2.4 million tons of in-place fine refuse reserves. […]

Mergers & Acquisitions

Warner Bros. Television Group Enters Into Agreement to Acquire the Eyeworks Group in Deal That Grows International TV Production Business

Warner Bros. Television Group Enters Into Agreement to Acquire the Eyeworks Group in Deal That Grows International TV Production Business PR Newswire AMSTERDAM, LONDON, and BURBANK, California, February 11, 2014 AMSTERDAM , LONDON , and BURBANK, California , February 11, 2014 /PRNewswire/ — Eyeworks USA to Remain Independent As part of the studio’s television growth strategy, Warner Bros. Television Group today announced that it has entered into an agreement to acquire¹ all Eyeworks’ businesses outside the US, in 15 countries across Europe , South America , Australia and New Zealand , adding 13 new territories to its network of production companies. […]

Mergers & Acquisitions

Debiopharm Group to Acquire Affinium’s Antibiotic Clinical Assets and Platform to Identify and Develop Targeted Antibiotics

Debiopharm Group to Acquire Affinium’s Antibiotic Clinical Assets and Platform to Identify and Develop Targeted Antibiotics PR Newswire LAUSANNE, Switzerland, February 11, 2014 LAUSANNE , Switzerland , February 11, 2014 /PRNewswire/ — Debiopharm Group ™ (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, and Affinium Pharmaceuticals (Affinium), a Canadian company focusing on the development of a platform of novel, targeted narrow-spectrum antibacterial therapeutics, today announced the acquisition by Debiopharm of Affinium’s clinical and preclinical assets as well as its technology platform. The clinical assets include AFN-1252, a FabI inhibitor designated by the FDA as a Qualified Infectious Disease Product (QIDP) which has successfully completed a Phase 2a study for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and its prodrug AFN-1720, currently in Phase 1 clinical development. Both compounds are highly potent agents that are selectively active against all Staphylococcus species and strains tested thus far (5400 strains) including all known resistant strains such as methicillin-resistant S […]

Technicals

Changyou.com (CYOU) Falls: Stock Tanks 10.7% – Tale of the Tape

Changyou.com Limited ( CYOU ) saw a big move last session, as the company’s shares fell nearly 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $27.82 to $31.51 in the past one-month time frame. […]